Ductal Carcinoma In Situ Is Common and Nearly Always Curable
Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, is a type of breast cancer where the cells have not spread through the duct walls into the other breast tissue. DCIS is considered a non-invasive breast cancer, though it is also considered pre-invasive because it may spread if left untreated. It is estimated that roughly one in five new cases of breast cancer will be intraductal carcinoma, and because it is an early stage of cancer, most individuals diagnosed can usually be cured.
DCIS breast cancer is often treated in one or more of the following ways:
- Breast-conserving surgery – Also known as partial or segmental mastectomy, lumpectomy, or quadrantectomy, this involves the removal of only the part of the breast that contains the cancer.
- Simple mastectomy – Also known as total mastectomy, this involves the removal of the entire breast, including the nipple, but not the lymph nodes from under the arm or the muscle tissue beneath the breast.
- External beam radiation therapy – High-energy rays or particles are beamed at the cancer cells to destroy them; this is the most common radiation therapy for breast cancer and is usually used after a lumpectomy is performed to decrease the likelihood that the cancer will return.
- Brachytherapy – Also known as internal radiation, this involves the insertion of radioactive seeds or pellets into a device in the breast tissue where the cancer has been.
Individuals who have been diagnosed with ductal carcinoma in situ or another form of breast cancer may contact Tampa General Hospital to schedule an appointment for proper treatment. TGH has a multi-specialty team of cancer specialists and other medical professionals that is dedicated to providing compassionate care to our patients and works hard to develop individualized treatment plans for each patient’s case in order to achieve the best possible outcome. For a physician referral or to make an appointment, please call (813) 844-2200.